Endo

PhaseBio Pharmaceuticals, located in Malvern, PA, is dedicated to developing innovative therapies for cardiovascular diseases, which currently affect one in four individuals. The company aims to address the pressing need for new treatment options by leveraging high-quality science and the expertise of its team to create a unique pipeline of medicines. Committed to improving patient outcomes and enhancing the healthcare system, PhaseBio focuses on overcoming the challenges associated with serious cardiovascular conditions. Their mission underscores a determination to deliver specialized therapies that can provide superior results for patients in need. Generated from the website

Infinity Compounding, located in Logan Twp, NJ, is a leading specialty engineered thermoplastics compounder with global manufacturing capabilities. They offer a broad range of thermoplastic resins, including pre-color and custom compound development, and are known for their speed, service, and technical expertise. With over 20 production lines, in-house R&D laboratories, and a commitment to quality through continuous improvement and customer satisfaction, Infinity Compounding delivers superior quality plastic compounding and color accuracy across all of their product lines. With facilities in Morrisville, PA, Swedesboro, NJ, Suzhou, China, and Ribe, Denmark, Infinity Compounding has experienced steady growth and expansion to meet the increasing demand from customers. Their materials are used in various industries where property, performance, and color accuracy are crucial to customer quality. Offering both custom compounded materials and proprietary product lines, Infinity Compounding combines big company capabilities with the personalized attention of a small company.Generated from the website

Iroko Pharmaceuticals is an independent management company based in Philadelphia, specializing in investment strategies focused on real estate. The firm offers a range of funds, including those that invest in social economy and solidarity sectors, catering primarily to professional investors. Founded in 2020, Iroko aims to provide innovative investment solutions while prioritizing long-term value creation. The company emphasizes the importance of understanding investment risks and encourages investors to seek independent financial advice before making decisions. Generated from the website